Immune checkpoint inhibitors, highly-active antiretroviral therapy interferons, and tumor necrosis factor (TNF-α) antagonists are the pharmacological classes most frequently linked to these drug-induced sarcoidosis-like reactions (DISRs) [72]. This evidence concerns the gene TNF and sarcoidosis.